{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:40:45Z","timestamp":1783716045148,"version":"3.55.0"},"reference-count":10,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"Abstract<\/jats:title>\n \n Context:<\/jats:title>\n Familial chylomicronemia syndrome (FCS) is a rare heritable disorder associated with severe hypertriglyceridemia and recurrent pancreatitis. Lipoprotein lipase deficiency and apolipoprotein C-II deficiency are two well-characterized autosomal recessive causes of FCS, and three other genes have been described to cause FCS. Because therapeutic approaches can vary according to the underlying etiology, it is important to establish the molecular etiology of FCS.<\/jats:p>\n <\/jats:sec>\n \n Case Description:<\/jats:title>\n A man originally from North Africa was referred to the University of Pennsylvania Lipid Clinic for severe hypertriglyceridemia and recurrent pancreatitis, consistent with the clinical diagnosis of FCS. Molecular analyses of FCS-associated genes revealed a homozygous missense variant R72T in APOC2. Molecular modeling of the variant predicted that the apolipoprotein C-II R72T peptide has reduced lipid binding affinity. In vitro studies of the patient\u2019s plasma confirmed the lack of functional apoC-II activity. Moreover, the apoC-II protein was undetectable in the patient\u2019s plasma, quantitatively as well as qualitatively.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n We identified a missense APOC2 variant causing apoC-II deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis. Beyond dietary management and usual pharmacologic therapies, an apoC-II mimetic peptide may become an optional therapy in patients with apoC-II deficiency in the future.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/jc.2016-3903","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:10:17Z","timestamp":1492614617000},"page":"1454-1457","source":"Crossref","is-referenced-by-count":42,"title":["A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis"],"prefix":"10.1210","volume":"102","author":[{"given":"Masako","family":"Ueda","sequence":"first","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Dunbar","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wolska","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey U.","family":"Sikora","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Rosario","family":"Escobar","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Seliktar","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"deGoma","sequence":"additional","affiliation":[{"name":"Akebia Therapeutics, Cambridge, Massachusetts 02142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"DerOhannessian","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Morrell","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, Western University, London, Ontario N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Burke","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sviridov","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Amar","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Shamburek","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lita","family":"Freeman","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[{"name":"Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, Western University, London, Ontario N6A 5B7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20894"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"2020071620133555800_B1"},{"issue":"6","key":"2020071620133555800_B2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia: current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2020071620133555800_B3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.1981.tb01768.x","article-title":"Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion","volume":"11","author":"Miller","year":"1981","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"2020071620133555800_B4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2015.158","article-title":"Long-term retrospective analysis of gene therapy with alipogene tiparvovec and its effect on lipoprotein lipase deficiency-induced pancreatitis","volume":"27","author":"Gaudet","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"4","key":"2020071620133555800_B5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"issue":"2","key":"2020071620133555800_B6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.114.220418","article-title":"A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice","volume":"352","author":"Amar","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071620133555800_B7","doi-asserted-by":"crossref","unstructured":"Freeman LA. Western blots. In: Freeman L, ed. Lipoproteins and Cardiovascular Disease: Methods and Protocols. New York, NY: Humana Press; 2013:369\u2013385.","DOI":"10.1007\/978-1-60327-369-5_18"},{"issue":"3","key":"2020071620133555800_B8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-5793(74)80064-5","article-title":"A molecular theory of lipid-protein interactions in the plasma lipoproteins","volume":"38","author":"Segrest","year":"1974","journal-title":"FEBS Lett"},{"issue":"7","key":"2020071620133555800_B9","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/bi0267184","article-title":"Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase","volume":"42","author":"Zdunek","year":"2003","journal-title":"Biochemistry"},{"issue":"2","key":"2020071620133555800_B10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.115.229740","article-title":"Creation of apolipoprotein C-II (ApoC-II) mutant mice and correction of their hypertriglyceridemia with an ApoC-II mimetic peptide","volume":"356","author":"Sakurai","year":"2016","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/5\/1454\/16630132\/jc.2016-3903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/5\/1454\/16630132\/jc.2016-3903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:07:33Z","timestamp":1594962453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/5\/1454\/2982061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3903","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,2,13]]}}}